$1.13
-0.02[-1.74%]
At close: Apr 25
$1.13
0[0.00%]
After Hours: 8:56AM EDT
Nanoviricides
(AMEX:NNVC)Latest News for Nanoviricides Stock (AMEX:NNVC)
Nanoviricides Stock (AMEX: NNVC)
Categories: All
Friday, February 16, 2024
Thursday, February 01, 2024
Wednesday, January 31, 2024
Monday, January 08, 2024
Tuesday, September 26, 2023
Monday, September 18, 2023
Tuesday, August 22, 2023
Monday, August 21, 2023
- NanoViricides shares are trading higher after the company announced progress for the Phase 1a/1b Human Clinical Trial of NV-CoV-2.Benzinga Newsdesk - Aug 21, 2023, 11:02AM
- Nanoviricides Reported That The Phase 1a/1b Human Clinical Trial Of NV-CoV-2, The Company's Broad-spectrum Antiviral Drug, Is Progressing SuccessfullyBenzinga Newsdesk - Aug 21, 2023, 6:52AM
Tuesday, July 18, 2023
Tuesday, July 11, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jul 11, 2023, 1:37PM
- Why Are NanoViricides Shares Gaining TodayVandana Singh - Jul 11, 2023, 12:51PM
- NanoViricides shares are trading higher after the company reported effectiveness of antiviral drug candidate in animal model with respiratory syncytial virus infection.Benzinga Newsdesk - Jul 11, 2023, 12:18PM
- Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving PremarketLisa Levin - Jul 11, 2023, 8:33AM
- NanoViricides Reports Effectiveness Of Antiviral Clinical Drug Candidate NV-387 In An Animal Model Of Lethal Lung Infection With Respiratory Syncytial VirusBenzinga Newsdesk - Jul 11, 2023, 6:50AM
Monday, July 10, 2023
Thursday, July 06, 2023
- NanoViricides Says Clinical Trial Of Broad-Spectrum Antiviral Drug NV-CoV-2 Is Progressing Well - NV-CoV-2 Is Positioned To Fulfill Many Unmet Medical NeedsHappy Mohamed - Jul 6, 2023, 10:35AM
- NanoViricides Says Clinical Trial Of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Is Progressing SatisfactorilyBenzinga Newsdesk - Jul 6, 2023, 6:46AM
Wednesday, July 05, 2023
Friday, June 02, 2023
Thursday, June 01, 2023
Tuesday, May 16, 2023
Tuesday, April 25, 2023
Tuesday, April 18, 2023
Monday, April 17, 2023
Friday, April 07, 2023
Thursday, April 06, 2023
Tuesday, April 04, 2023
- Nanoviricides shares are trading higher after the company announced it executed a license agreement with Karveer Meditech. Under this Agreement, Karveer has the right to commercialize the company's COVID drugs NV-CoV-2 and NV-CoV-2-R in India.Benzinga Newsdesk - Apr 4, 2023, 3:05PM
- Nanoviricides Has Executed A License Agreement With Karveer Meditech Pvt. Ltd Based In India, To Commercialize The Company's COVID Drugs In IndiaBenzinga Newsdesk - Apr 4, 2023, 7:47AM
Tuesday, February 28, 2023
Thursday, October 27, 2022
Thursday, August 18, 2022
Wednesday, August 10, 2022
Tuesday, August 09, 2022
Friday, August 05, 2022
Thursday, August 04, 2022
- Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Aug 4, 2022, 1:12PM
- Ten Stocks Trending on Discord for Thursday August 4, 2022: NVIV, COIN, APDN, STAF, NNVC, AMC, NERV, TSLA, AWX, CCXICharles Gross - Aug 4, 2022, 11:12AM
- NanoViricides shares are trading higher after the company announced it has begun drug development to combat Monkeypox virus.Benzinga Newsdesk - Aug 4, 2022, 10:16AM
- NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox VirusCharles Gross - Aug 4, 2022, 6:46AM